Cours DelMar Pharmaceuticals Inc Nasdaq
Actions
US2470782077
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 6,82 M 6,22 M |
---|---|---|---|---|---|
Résultat net 2022 | -22 M -20,06 M | Résultat net 2023 | -14 M -12,76 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 11,78 M 10,74 M | Trésorerie nette 2023 | 2,61 M 2,38 M | VE / CA 2023 | - |
PER 2022 |
-0,54
x | PER 2023 |
-0,43
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,81% |
Dernier transcript sur DelMar Pharmaceuticals Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11/04/18 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11/04/18 |
Tamara Favorito
BRD | Director/Board Member | 65 | 29/04/21 |
Laura Douglass
BRD | Director/Board Member | 59 | 26/06/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,58% | 103 Md | |
+1,37% | 95,28 Md | |
+1,75% | 22,15 Md | |
-15,67% | 21,02 Md | |
-8,19% | 18,15 Md | |
-41,01% | 16,73 Md | |
-13,43% | 16,05 Md | |
+4,13% | 13,68 Md | |
+34,55% | 12,17 Md |